ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab - תרכיז להכנת תמיסה לאינפוזיה - pertuzumab 420 mg / 14 ml - pertuzumab - pertuzumab - perjeta is indicated in combination with trastuzumab and docetaxel for the treatment of patients with her2 positive metastatic breast cancer who have not received prior anti-her2 therapy or chemotherapy for metastatic disease.

ישראל - עברית - Ministry of Health

sanofi israel ltd - alemtuzumab - תרכיז להכנת תמיסה לאינפוזיה - alemtuzumab 12 mg / 1.2 ml - alemtuzumab

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - gemtuzumab ozogamicin - אבקה להכנת תמיסה מרוכזת לעירוי - gemtuzumab ozogamicin 5 mg/vial - gemtuzumab

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab; trastuzumab - תמיסה להזרקה - trastuzumab 40 mg/ml; pertuzumab 80 mg/ml - pertuzumab and trastuzumab

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab; trastuzumab - תמיסה להזרקה - trastuzumab 60 mg/ml; pertuzumab 60 mg/ml - pertuzumab and trastuzumab

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - trastuzumab emtansine - אבקה להכנת תמיסה מרוכזת לעירוי - trastuzumab emtansine 20 mg/ml - trastuzumab

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate

ישראל - עברית - Ministry of Health

medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate